| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |